
The Root Cause Medicine Podcast
Rupa HealthAudio
- Format:
- Podcast
- New episodes:
- Weekly
- Typical length:
- about 50 minutes
- Latest episode:
About this show
In each episode, we’ll meet renowned medical experts, specialists and pioneers who’ve influenced the way certain conditions and diseases are understood and treated. We focus on giving you the information you need to understand the root cause, symptoms and treatments available for specific medical conditions.
Covers: integrative medicine, functional medicine, nutrition science, gut microbiome, inflammation, botanical supplements, depression treatment, immune system, supplement quality, clinical practice
Show details and episodes come from the publisher's public feed at feeds.cohostpodcasting.com. Last updated . Names, artwork and text belong to their publishers.
Recently on this show
Summary of recent episodes, drawn from the publisher's feed.
The Root Cause Medicine Podcast features medical experts and specialists discussing the causes, symptoms and treatments of specific conditions and diseases. Recent episodes cover gut microbiome research, inflammation and specialized pro-resolving mediators, depression and antidepressant withdrawal, and menopause botanicals.
Cosmos
Similar in subject
- Get Better Faster
Both cover: inflammation, functional medicine - hol+ with Dr. Taz MD | The Future of Medicine is Holistic
Both cover: integrative medicine, functional medicine - Sigma Nutrition Radio
Both cover: gut microbiome, nutrition science
Similar shows
Explore more
Episodes
He Built the “MRI for the Microbiome”. Now Everyone Can Access It.
· 1 hr 5 min
Host Kate joins Leo Grady, PhD, founder and CEO of Jona, to explore AI-assisted microbiome analysis, shotgun sequencing, and personalized nutrition. Inspired to build Jona after his son suffered from severe gut issues that kept him out of school—and is now healthy—Grady explains how the platform processes the equivalent of 8 MRIs worth of data per test. They also discuss digital-twin simulations, research transparency, and translating complex stool-test data into clinician-reviewed plans. Guest Leo Grady, PhD, is Jona’s founder and CEO. His background includes AI applications in radiology, cardiovascular assessment, and pathology at Siemens, HeartFlow, and Paige AI. Key Takeaways - AI microbiome analysis moves beyond species counts. Learn how combining shotgun sequencing with published clinical research maps functional potential and complex microbial patterns.https://www.nature.com/articles/nbt.3935(Quince 2017) (https://www.nature.com/articles/nbt.3935) - Digital-twin technology informs clinician-led care. Explore how predictive simulations model response to targeted nutrition and personalized supplements while keeping practitioners in control.https://journals.asm.org/doi/10.1128/msystems.00606-19(Diener 2020) (https://journals.asm.org/doi/10.1128/msystems.00606-19) (Porcari 2025) (https://www.sciencedirect.com/science/article/abs/pii/S246812532400311X) - Shotgun sequencing delivers deep functional insights. Discover how processing extensive stool-sequencing datasets translates complex microbial metabolic capacity into actionable clinical guidance.https://www.nature.com/articles/nbt.3935(Quince 2017) (https://www.nature.com/articles/nbt.3935) Clinical FAQ 1. How does AI-assisted gut microbiome testing analyze stool samples? Shotgun sequencing data is compared against published human clinical studies using advanced AI algorithms to detect microbial patterns and summarize functional potential.https://www.nature.com/articles/nbt.3935(Quince 2017) (https://www.nature.com/articles/nbt.3935) 2. What is a gut microbiome digital twin and how is it used? A microbiome digital twin is a computational simulation that predicts potential shifts in microbial activity following dietary, lifestyle, or targeted supplement interventions. (Diener 2020) (https://journals.asm.org/doi/10.1128/msystems.00606-19) 3. Can AI microbiome testing replace standard clinical diagnosis? No. Stool testing and AI models provide functional insights but do not replace validated diagnostic tools or practitioner oversight.https://www.sciencedirect.com/science/article/abs/pii/S246812532400311X(Porcari 2025) (https://www.sciencedirect.com/science/article/abs/pii/S246812532400311X) Timestamps 02:57 Grady’s AI and healthcare background 11:39 Why he founded Jona (his son's severe gut health journey and recovery) 22:20 Health domains and report structure 30:09 Functional capacity versus blood measurements 36:17 Digital-twin simulations 55:16 Sequencing workflow and evidence review Ready to elevate your practice? This episode is sponsored byhttps://app.asana.com/1/114892498683045/project/1220028987700740/list/1220028927202319Fullscript (https://fullscript.com/?utm_campaign=rootcausemedicinepodcast&utm_medium=podcast&utm_source=fullscript-academy), a comprehensive care delivery platform designed to support whole-person, integrative healthcare. Fullscript helps clinicians bring supplement dispensing, lab ordering, and patient education into one centralized workflow. For more practitioner education on supplements, nutrition, and evidence-informed clinical care, visit Fullscript Academy athttp://academy.fullscript.comacademy.fullscript.com (http://academy.fullscript.com). Disclaimer: The views expressed on this podcast are those of the hosts and guests and don’t necessarily reflect those of Fullscript or any affiliated organizations. This podcast is for informational and educational purposes only and is not intended to be medical advice. For your…
Not rated yetResolving vs. Reducing Inflammation: What Clinicians Need to Know about SPMs
· 32 min
On the Root Cause Medicine Podcast, Dr. Lara Zakaria joins Dr. Malisa Carulo to explore specialized pro-resolving mediators (SPMs), omega-3-derived precursors, and emerging pain research, with a focus on evidence limits and clinical decision-making. Clinical Takeaways - Distinguish SPMs from their precursors. TSPMs are lipid signals that help steer inflammation toward resolution. (Serhan 2018) (https://www.jci.org/articles/view/97943) SPM-focused marine-oil supplements contain upstream intermediates, a few enzymatic steps closer to finished SPMs than EPA and DHA, but these are not equivalent to finished SPMs.https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.119.315506(Souza 2020) (https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.119.315506) - Separate mechanisms from clinical outcomes. condition.Mechanistic research outpaces human trials, which so far center on pain and musculoskeletal conditions such as osteoarthritis.https://link.springer.com/article/10.1186/s12967-020-02569-5(Callan 2020) (https://link.springer.com/article/10.1186/s12967-020-02569-5)https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04283-4(Möller 2023) (https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04283-4) Evidence does not yet support broad benefits for autoimmune disease, gut health, or every inflammatory condition. - Keep clinical response central. The conversation emphasizes pain, stiffness, and mobility alongside foundational care. Acute high-dose strategies and bedtime use are discussed as anecdotes, not validated protocols. Guest Dr. Malisa Carulo holds a doctorate in naturopathic medicine and an MS in biology. Introduced as Senior Manager of Medical Information and Safety at Metagenics, her interests include chronic disease, healthy aging, and sports medicine. Clinician FAQ 1. What are specialized pro-resolving mediators? SPMs, including resolvins, protectins, and maresins, as lipid signals involved in the active resolution of inflammation.https://www.jci.org/articles/view/97943(Serhan 2018) (https://www.jci.org/articles/view/97943) 2. How do SPM-focused supplements differ from fish oil? The guest distinguishes EPA and DHA from downstream intermediates such as 18-HEPE, 17-HDHA, and 14-HDHA. This distinction alone does not establish superior clinical outcomes. (Möller 2023) (https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04283-4) 3. What evidence for SPMs and joint pain does the episode discuss? The guest highlights early human research in musculoskeletal pain, including osteoarthritis, while acknowledging that clinical evidence remains limited relative to mechanistic research.https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04283-4(Callan 2020) (https://link.springer.com/article/10.1186/s12967-020-02569-5)https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04283-4(Möller 2023) (https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04283-4) 4. Are SPM supplements established therapies for autoimmune or gut conditions? The discussion does not establish that use. The guest describes clinical experiences and biological hypotheses rather than condition-specific evidence sufficient to support broad treatment claims. 5. Does the episode establish an SPM dosing protocol? No. Studies have used doses ranging from about 250 mg per day in early research to 500 mg and 1 g in human trials, but the guest cautions that evidence-guided dosing recommendations remain limited.https://link.springer.com/article/10.1186/s12967-020-02569-5(Callan 2020) (https://link.springer.com/article/10.1186/s12967-020-02569-5)https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04283-4(Möller 2023) (https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04283-4) Key Moments 03:56 SPM biology and marine-oil intermediates 07:42 Conversion pathways…
Not rated yetDepression, Nutrition, and Antidepressant Withdrawal: A Whole-Person Perspective
· 51 min
Dr. Kate Kresge is joined by psychiatrist James Greenblatt, MD, to discuss themes from his book Finally Hopeful, including nutrition, depression, laboratory assessment, and antidepressant withdrawal. Clinical Takeaways - Depression warrants a broad clinical assessment. Symptoms may overlap with medical conditions and nutritional deficiencies. (Bode 2021) (https://pubmed.ncbi.nlm.nih.gov/34524390/)https://pubmed.ncbi.nlm.nih.gov/32291287/(Lee 2020) (https://pubmed.ncbi.nlm.nih.gov/32291287/)https://pubmed.ncbi.nlm.nih.gov/28759846/(Bender 2017) (https://pubmed.ncbi.nlm.nih.gov/28759846/) The episode discusses thyroid function, iron, vitamin B12, folate, vitamin D, and other factors as part of a broader evaluation—not as universal causes of depression. - Antidepressant discontinuation should be individualized. Abruptly stopping an antidepressant can cause withdrawal symptoms. (Henssler 2024) (https://pubmed.ncbi.nlm.nih.gov/38851198/)https://pubmed.ncbi.nlm.nih.gov/30850328/(Horowitz 2019) (https://pubmed.ncbi.nlm.nih.gov/30850328/) Gradual, clinician-supervised tapering is important; nutritional status may also be considered, although supplementation has not been established as a way to prevent withdrawal. (Horowitz 2019) (https://pubmed.ncbi.nlm.nih.gov/30850328/) - Nutrition can be considered within whole-person mental healthcare. Protein, amino acids, omega-3 fatty acids, B vitamins, zinc, and magnesium are discussed. Testing and supplementation should reflect individual needs rather than assuming a common deficiency. Guest: James Greenblatt, MD James Greenblatt, MD, is a psychiatrist and educator in integrative and functional psychiatry. He discusses a whole-person framework for evaluating depression, nutritional status, and antidepressant discontinuation. Clinician FAQ 1. Can nutritional deficiencies contribute to depressive symptoms? Yes, nutritional status can be clinically relevant, but depression is multifactorial. (Bender 2017) (https://pubmed.ncbi.nlm.nih.gov/28759846/)https://pubmed.ncbi.nlm.nih.gov/30396512/(Malhi 2018) (https://pubmed.ncbi.nlm.nih.gov/30396512/) The episode discusses iron, vitamin B12, folate, vitamin D, zinc, and other nutrients clinicians may evaluate when appropriate. 2. Why distinguish antidepressant withdrawal from depression? Withdrawal can occur when antidepressants are reduced or stopped, and symptoms may overlap with psychiatric symptoms. (Henssler 2024) (https://pubmed.ncbi.nlm.nih.gov/38851198/)https://pubmed.ncbi.nlm.nih.gov/30850328/(Horowitz 2019) (https://pubmed.ncbi.nlm.nih.gov/30850328/) Distinguishing withdrawal from recurrence of depression is important during discontinuation. (Horowitz 2019) (https://pubmed.ncbi.nlm.nih.gov/30850328/) 3. Should nutritional status be assessed before antidepressant tapering? The episode proposes evaluating nutritional status before and during tapering. Medication changes should be individualized and managed with the prescribing clinician. 4. What role do amino acids play in mental health? Amino acids from dietary protein are precursors for many biologically important molecules, including neurotransmitters. (Tang 2025) (https://pubmed.ncbi.nlm.nih.gov/40998119/) The episode discusses amino acid assessment as part of Dr. Greenblatt’s clinical approach. 5. Why screen for medical conditions in patients with depression? Some medical conditions may produce symptoms that resemble or coexist with depression. (Bode 2021) (https://pubmed.ncbi.nlm.nih.gov/34524390/)https://pubmed.ncbi.nlm.nih.gov/32291287/(Lee 2020) (https://pubmed.ncbi.nlm.nih.gov/32291287/)https://pubmed.ncbi.nlm.nih.gov/31947912/(Clappison 2020) (https://pubmed.ncbi.nlm.nih.gov/31947912/) The episode highlights thyroid disorders, anemia, and celiac disease as examples clinicians may investigate when clinically indicated. Key Moments 03:44 Whole-person framework for depression 07:46 Antidepressant withdrawal 11:29 Nutritional assessment before tapering 23:23 Amino…
Not rated yetFirst Aid Kit for Cold and Flu Season
· 40 min
What to do at the first sign of a cold: an evidence-informed toolkit Dr. Holly Lucille, ND, is joined by Lara Zakaria, PharmD, MS, CNS, to discuss what people can do when a scratchy throat, fatigue, or other early respiratory symptoms begin. The conversation covers rest and recovery, respiratory virus testing, zinc, vitamin C, elderberry, echinacea, honey, green tea, garlic, ginger, turmeric, and practical ways to prepare for cold and flu season. Early symptoms of COVID-19, influenza, and other respiratory infections can overlap, making symptom pattern alone an unreliable way to identify the cause. Testing, individual risk factors, symptom severity, and timing can all affect the appropriate next step. (CDC 2026a) (https://www.cdc.gov/respiratory-viruses/about/index.html)https://www.cdc.gov/respiratory-viruses/prevention/testing.html(CDC 2025) (https://www.cdc.gov/respiratory-viruses/prevention/testing.html) Clinical Takeaways - Start with the fundamentals: rest, fluids, testing when appropriate, and risk assessment. Most uncomplicated colds improve without specific treatment, and supportive measures such as adequate rest and fluids remain foundational. (CDC 2026b) (https://www.cdc.gov/common-cold/treatment/index.html) Testing can help distinguish respiratory infections such as COVID-19 and influenza when the result may affect treatment or precautions, particularly for patients at higher risk of severe illness. (CDC 2025) (https://www.cdc.gov/respiratory-viruses/prevention/testing.html) - Zinc and vitamin C have different levels of evidence for the common cold. Zinc has been studied extensively, particularly as lozenges started early in a cold, but results vary substantially by formulation, dose, and study design. (Nault 2024) (https://pubmed.ncbi.nlm.nih.gov/38719213/)https://pubmed.ncbi.nlm.nih.gov/28480298/(Hemilä 2017) (https://pubmed.ncbi.nlm.nih.gov/28480298/)https://pubmed.ncbi.nlm.nih.gov/31980506/(Hemilä 2020) (https://pubmed.ncbi.nlm.nih.gov/31980506/) Regular vitamin C supplementation may modestly shorten cold duration, while evidence for starting vitamin C only after symptoms appear has been less consistent. Long-term or excessive zinc supplementation also warrants attention because sustained high intake can interfere with copper status. (NIH 2022) (https://ods.od.nih.gov/factsheets/Copper-HealthProfessional/) - Botanical evidence is ingredient- and formulation-specific. (Karsch-Völk 2014) (https://pubmed.ncbi.nlm.nih.gov/24554461/) Elderberry and echinacea have both been studied for respiratory infections, but findings are mixed and should not be generalized across products. (Wieland 2021) (https://pubmed.ncbi.nlm.nih.gov/33827515/)https://pubmed.ncbi.nlm.nih.gov/24554461/(Karsch-Völk 2014) (https://pubmed.ncbi.nlm.nih.gov/24554461/)https://pubmed.ncbi.nlm.nih.gov/31126553/(David 2019) (https://pubmed.ncbi.nlm.nih.gov/31126553/) Evidence for elderberry remains limited and uncertain, while echinacea studies vary considerably according to species, plant part, extraction method, and formulation. (Wieland 2021) (https://pubmed.ncbi.nlm.nih.gov/33827515/)https://pubmed.ncbi.nlm.nih.gov/24554461/(Karsch-Völk 2014) (https://pubmed.ncbi.nlm.nih.gov/24554461/) Garlic, green tea, ginger, turmeric, and honey may have nutritional or symptom-support roles, but they should not be presented as established treatments for viral respiratory infections. (Lissiman 2014) (https://pubmed.ncbi.nlm.nih.gov/25386977/)https://pubmed.ncbi.nlm.nih.gov/32817011/(Abuelgasim 2021) (https://pubmed.ncbi.nlm.nih.gov/32817011/) Guest: Lara Zakaria, PharmD, MS, CNS Lara Zakaria is a pharmacist and clinical nutritionist with a background spanning community pharmacy, functional medicine, and personalized nutrition. In this episode, she discusses how conventional pharmacy knowledge and nutrition can be brought together when thinking about early respiratory symptoms, supplement use, and practical supportive care. Clinician FAQ 1. What should…
Not rated yetHealth Meets Wellness: The App and Dr. Edens’ Story
· 46 min
Health Meets Wellness: The App and Dr. Edens’ Story Dr. Elizabeth Sharp Edens is the founder of Health Meets Wellness, an integrative practice where every patient gets three plans: a medical plan, a movement plan and a nutrition plan. Guideline-based medicine is her North Star, and she layers in nutrition, yoga, herbal therapies and acupuncture, with dietitians on her team. It’s whole-person care built around how each patient actually lives. But she didn’t stop at the exam room. She’s spent three years building the Health Meets Wellness app to bring that same care to patients between visits, and to people far beyond her own practice. It features meal plans, photo food logging, an AI health coach, symptom tracking for patients on GLP-1s, yoga videos she filmed herself, and 20-minute, no-equipment strength workouts developed with a former Milwaukee Bucks performance lead. Now it’s being rebranded for women, with cycle tracking that adapts meal and exercise plans to each phase. There’s a free version, and practitioners can use it with their own patients. Elizabeth is double board-certified in internal medicine and obesity medicine, certified in functional medicine and a certified yoga instructor, and her path ran through Mount Sinai, a healthcare startup and One Medical. We talk about how she built her practice and her app without a tech background, why she became a yoga teacher, and how she supports patients on GLP-1s with movement and nutrition. If you love whole-person care but work in a hospital or conventional system without a roadmap, this one’s for you. Timestamps - 03:33 — What drew Dr. Elizabeth to medicine, and then to functional medicine - 08:15 — What her practice looks like today - 11:25 — From Mount Sinai to a startup to One Medical to her own practice - 14:14 — How to find opportunities beyond one-to-one care - 18:38 — Why she built an app, and why it’s designed for women - 25:54 — Advice if you’re not tech-savvy - 28:57 — Why she became a yoga teacher + fitting training into a full schedule - 32:25 — Metabolic health and what she sees as non-negotiable with GLP-1s - 35:41 — Movement on a GLP-1: building and measuring muscle at home Want to elevate your practice? This episode is sponsored by Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates), a comprehensive care delivery platform designed to support whole-person, integrative healthcare. Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates)allows clinicians to streamline supplement dispensing, lab ordering, and patient education in one free, centralized system—helping reduce administrative burden while supporting clinical decision-making. For practitioners, Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates) offers access to professional-grade supplements, evidence-informed protocols, and lab integrations that can support more efficient planning and follow-up. For patients, it provides a clear, organized way to receive recommendations, manage refills, and stay engaged in their care. The goal is not to replace clinical judgment, but to make it easier for clinicians to focus on what matters most: thoughtful, individualized patient care. Disclaimer: The views expressed on this podcast are those of the hosts and guests and don’t necessarily reflect those of Fullscript or any affiliated organizations. This podcast is for informational and educational purposes only and is not intended to be medical advice. For your safety, always check with your doctor or healthcare provider before making changes to your health routine.
Not rated yetThe Gut Ecosystem: An Update on How Keystone Species Shape the Microbiome
· 1 hr 5 min
Dr. Oscar Coetzee joins Dr Lara Zakaria on the Root Cause Medicine Podcast to discuss emerging research on keystone commensal organisms and how microbial communities interact within the gut ecosystem. The conversation focuses on organisms including Akkermansia muciniphila, Faecalibacterium prausnitzii, Roseburia, Bifidobacterium longum, and Bifidobacterium adolescentis. Rather than viewing individual microbes in isolation, Dr. Coetzee describes an ecosystem model centered on cross-feeding, short-chain fatty acid production, and the intestinal environment. The episode also notes an important context: research on next-generation commensals is still developing, meaning findings from mechanistic studies, case reports, and early clinical research offer initial insights that complement rather than replace evidence from larger randomized controlled trials. (Jan 2024) (https://pubmed.ncbi.nlm.nih.gov/39229543/)https://pubmed.ncbi.nlm.nih.gov/42104000/(Kern 2026) (https://pubmed.ncbi.nlm.nih.gov/42104000/) Clinical takeaways - Keystone organisms are discussed as members of an interconnected ecosystem. The episode explores how organisms can produce metabolites or modify environmental conditions that may influence other members of the microbial community. (Belzer 2017) (https://pubmed.ncbi.nlm.nih.gov/28928206/)https://pubmed.ncbi.nlm.nih.gov/37432351/(Fusco 2023) (https://pubmed.ncbi.nlm.nih.gov/37432351/) - Short-chain fatty acids are a major theme. Akkermansia, Faecalibacterium, and Roseburia are discussed in relation to acetate, propionate, and butyrate production and their potential roles within the intestinal environment. (Martin-Gallausiaux 2021) (https://pubmed.ncbi.nlm.nih.gov/32238208/)https://pubmed.ncbi.nlm.nih.gov/40788133/(Tingler 2025) (https://pubmed.ncbi.nlm.nih.gov/40788133/) - Clinical evidence remains emerging. Dr. Coetzee describes early clinical observations and studies in progress, while the conversation acknowledges the need for additional published research, including controlled trials, before broader clinical conclusions can be drawn. (Jan 2024) (https://pubmed.ncbi.nlm.nih.gov/39229543/)https://pubmed.ncbi.nlm.nih.gov/42104000/(Kern 2026) (https://pubmed.ncbi.nlm.nih.gov/42104000/) Guest: Oscar Coetzee, PhD, DCN Dr. Oscar Coetzee is Vice President of Clinical Education and Practitioner Support at Designs for Health. In the episode, he discusses his work in nutrition and microbiome research and his interest in next-generation commensal organisms. His discussion centers on moving beyond a single-organism view of probiotics toward understanding microbial communities, cross-feeding, and the environment in which commensal organisms coexist. Clinician FAQ 1. What are keystone commensal organisms? They are microbes discussed for their potentially important roles within the broader gut ecosystem. (Rios Garza 2026) (https://pubmed.ncbi.nlm.nih.gov/41478866/) The episode focuses on how selected commensals interact with other organisms and their environment rather than evaluating them solely by abundance. (Banerjee 2018) (https://pubmed.ncbi.nlm.nih.gov/29789680/) 2. Which organisms are discussed? The main organisms include Akkermansia muciniphila, Faecalibacterium prausnitzii, Roseburia, Bifidobacterium longum, and Bifidobacterium adolescentis. The conversation also discusses Anaerostipes caccae separately in the context of butyrate production and microbial cross-feeding. (Belzer 2017) (https://pubmed.ncbi.nlm.nih.gov/28928206/) 3. What is microbial cross-feeding? Cross-feeding describes how metabolites produced by one organism can serve as substrates or influence conditions for another. (Culp 2023) (https://pubmed.ncbi.nlm.nih.gov/37054671/)https://pubmed.ncbi.nlm.nih.gov/27928878/(Louis 2017) (https://pubmed.ncbi.nlm.nih.gov/27928878/) The episode uses this concept to explain why microbial communities may be more informative than considering individual organisms in isolation. (Culp 2023)…
Not rated yetMenopause Botanicals: Identity, Standardization & Patience
· 26 min
Dr. Eric Viegas joins the Root Cause Medicine Podcast to discuss an often-overlooked part of evaluating botanical supplements for menopause: whether the product being used actually matches the ingredient that was studied. The conversation focuses on five botanicals and botanical categories—black cohosh, Vitex (chasteberry), rhapontic rhubarb, maca, and soy isoflavones. Rather than framing individual herbs as simply effective or ineffective, Dr. Viegas emphasizes three considerations: identity, standardization, and patience. Identity refers to confirming the correct plant species and plant part. Standardization addresses whether relevant constituents or studied extracts are consistently represented in a product. Patience refers to allowing an appropriate evaluation period rather than judging a botanical after only a few days of use. Clinical takeaways - Botanical evidence is closely tied to the ingredient that was actually studied. Dr. Viegas emphasizes that results from research on a particular species, plant part, extract, or standardized preparation cannot automatically be generalized to every product carrying the same botanical name. - Black cohosh has a substantial research history, but product characteristics matter. The episode discusses Actaea racemosa and the importance of confirming botanical identity, the appropriate plant part, and the characteristics of the extract being used. Standardized preparations feature prominently in the research discussed. (Castelo-Branco 2021) (https://pubmed.ncbi.nlm.nih.gov/33021111/) (NIDDK 2025) (https://www.ncbi.nlm.nih.gov/books/NBK547990/) - Vitex is discussed primarily in the context of cyclical symptoms and perimenopause. Also known as chasteberry (Vitex agnus-castus), Vitex is presented as having a stronger research history for premenstrual and cyclical symptoms than for classic postmenopausal symptoms. The episode also highlights variation in extracts and marker compounds. (Csupor 2019) (https://pubmed.ncbi.nlm.nih.gov/31780016/) - Rhapontic rhubarb illustrates the importance of extract-specific evidence. The discussion focuses on the studied rhapontic rhubarb extract ERr 731 rather than treating all rhubarb preparations as interchangeable. This provides an example of why practitioners should identify the exact preparation evaluated in clinical research. (Dubey 2024) (https://pubmed.ncbi.nlm.nih.gov/38646867/) - Maca presents additional standardization challenges. The episode discusses differences among maca varieties and processing methods and notes that there is not one universally dominant marker used across all products. Maca is discussed in relation to menopausal symptoms, mood, and sexual function without positioning it as a direct hormone replacement. (Lee 2011) (https://pubmed.ncbi.nlm.nih.gov/21840656/) - Soy isoflavone response may vary between individuals and formulations. The conversation highlights differences among individual isoflavones and discusses equol production as one possible contributor to variability in response. (Mayo 2019) (https://www.mdpi.com/2072-6643/11/9/2231) - Time is part of interpreting a botanical trial. A recurring theme throughout the episode is that botanical interventions studied over weeks or months should not necessarily be judged after a very short trial. Appropriate duration depends on the ingredient, formulation, patient, and clinical context. Guest: Eric Viegas, ND Dr. Eric Viegas is a naturopathic doctor based in Ottawa, Canada, and works with Fullscript’s quality program. In the episode, he describes Fullscript’s approach to supplement quality, including supplier qualification and review of product documentation. He also discusses Fullscript Tested, a program in which products are selected from Fullscript distribution centers and submitted to third-party laboratories for testing related to factors such as identity, potency, and contaminants. His discussion of menopause botanicals centers on connecting published…
Not rated yetMeet the New Voices of the Root Cause Medicine Podcast
· 55 min
You've been hearing new voices in the host chair lately — so this week we're pulling back the curtain to introduce them properly. Dr. Kate Kresge sits down with Dr. Holly Lucille, Dr. Lara Zakaria, and Dr. Jessica Christie for a roundtable on the winding, deeply personal paths that led each of them into root-cause medicine. A pharmacist nearly buried under her own stack of nutrition books who came out dual-licensed. A psychology student who couldn't find a medical school that took food and sleep seriously, so she built her own path. A holistic nurse turned naturopathic doctor who fought for her profession on the statehouse floor. And a host whose decade-long "mystery illness" resolved in three days once the right test was finally run. What ties them together is a stubborn refusal to stop at the easy answer — the instinct to say, let's think this through, because so often the protocol failed the patient, not the other way around. Consider this your proper introduction to the team learning and sharing what works, right alongside you. What you'll hear - Why every one of these clinicians came to functional medicine as a "detective" — and often as a patient first. - Dr. Lara Zakaria's path from community pharmacist to dual-licensed nutritionist, and a clear-eyed explainer on what the CNS credential actually requires. - Dr. Jessica Christie's move from developmental psychology into naturopathic medicine, becoming her own first patient, and finding her way into fertility and women's health. - Dr. Holly Lucille's journey through holistic nursing and naturopathic medicine — and helping pass California's ND licensing bill (SB 907) in 2004. - Dr. Kate Kresge's decade of misdiagnosed illness that resolved in days once the root cause was identified — and why it reshaped how she thinks about mental-health symptoms with a physiological root cause. - How Rupa and Fullscript coming together puts labs, education, boot camps, webinars and AI-assisted evidence in one free place for clinicians. - The team's reframe of "the patient failed treatment" into "the treatment failed the patient" — and what patient-centered care really means. Key themes - Let's think things through — clinical reasoning over the 15-minute prescribe-and-go visit. - The empowered, informed patient is a good thing; clinicians add the nuance. - Whole-person care means mind and body are never truly separate. - Personalization: the protocol fits the patient, not the other way around. Timestamps - 02:21 — Welcoming the hosts - 03:13 — Naming the listeners - 05:35 — "Let's think things through" - 06:40 — Nuance and the empowered patient - 09:02 — Dr. Lara Zakaria's story - 12:16 — Dr. Jessica Christie's story - 16:00 — Rupa magazine + free education - 17:03 — What a CNS is - 20:10 — Dr. Holly Lucille's story - 28:17 — Whiskey Flower + Wipeout - 30:16 — Rupa + Fullscript coming together - 32:20 — AI Assist for whole-person care - 34:00 — Dr. Kate Kresge's story - 44:11 — The protocol failed the patient - 46:05 — What excites the team next - 53:21 — Wrap-up + listener name reveal Want to elevate your practice? This episode is sponsored by Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates), a comprehensive care delivery platform designed to support whole-person, integrative healthcare. Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates)allows clinicians to streamline supplement dispensing, lab ordering, and patient education in one free, centralized system—helping reduce administrative burden while supporting clinical decision-making. For practitioners, Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates) offers access to professional-grade supplements, evidence-informed protocols, and lab integrations that can support more…
Not rated yetC15:0, ferroptosis, and metabolic health: What practitioners should know
· 54 min
Dr. Lara Zakaria is joined by Stephanie Venn-Watson, DVM, MPH, to explore emerging research on pentadecanoic acid (C15:0), an odd-chain saturated fatty acid initially studied through research involving bottlenose dolphins. The conversation connects C15:0 with cell-membrane composition, lipid peroxidation, ferroptosis, iron metabolism, metabolic health, and steatotic liver disease. It also examines research on circulating C15:0 as a biomarker associated with cardiometabolic outcomes and early human trials of C15:0 supplementation. (Imamura 2018) (https://pubmed.ncbi.nlm.nih.gov/30303968/)https://pubmed.ncbi.nlm.nih.gov/33399331/(Sawh 2021) (https://pubmed.ncbi.nlm.nih.gov/33399331/) C15:0 has been proposed as a candidate essential fatty acid, however, that classification and a specific human “C15:0 deficiency syndrome” remain emerging hypotheses rather than established clinical diagnoses. Clinical Takeaways - Ferroptosis is an iron-dependent form of regulated cell death. First characterized in 2012, ferroptosis involves iron-dependent lipid peroxidation and differs mechanistically from apoptosis and other forms of cell death. (Dixon 2012) (https://pubmed.ncbi.nlm.nih.gov/22632970/) Polyunsaturated fatty acids in phospholipids are particularly relevant substrates for ferroptotic lipid peroxidation. (Yang 2016) (https://pubmed.ncbi.nlm.nih.gov/27506793/) - C15:0 is an odd-chain saturated fatty acid being studied for metabolic effects. Pentadecanoic acid, or C15:0, is found in dairy fat and smaller amounts in other foods. Higher circulating C15:0 has been associated with lower incidence of type 2 diabetes in prospective observational research, but these associations do not establish that C15:0 itself prevents diabetes. (Imamura 2018) (https://pubmed.ncbi.nlm.nih.gov/30303968/) - Calling C15:0 an “essential fatty acid” remains an emerging scientific proposal. Experimental work has proposed C15:0 as a candidate essential fatty acid based on dietary exposure, biological activity, and associations between circulating levels and health outcomes. More research is needed before C15:0 can be treated as equivalent to the established essential fatty acids linoleic acid and alpha-linolenic acid. (Venn-Watson 2020) (https://pubmed.ncbi.nlm.nih.gov/32424181/)(Venn-Watson 2022) (https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0268778) - Metabolic hyperferritinemia is a recognized clinical framework, but it is not synonymous with ferroptosis or C15:0 deficiency. Metabolic hyperferritinemia describes elevated ferritin occurring with metabolic dysfunction. Ferritin is also an acute-phase reactant, so elevated values require evaluation in clinical context rather than being interpreted as tissue iron overload by themselves.https://www.nature.com/articles/s41574-023-00807-6(Valenti 2023) (https://www.nature.com/articles/s41574-023-00807-6) - Human C15:0 supplementation evidence is early. Within this broader metabolic context, circulating C15:0 is an emerging biomarker of interest. In a small 12-week randomized, placebo-controlled trial in young adults with overweight or obesity, 200 mg/day oral C15:0 significantly increased circulating C15:0 concentrations. Exploratory analyses suggested that participants who achieved post-treatment circulating C15:0 concentrations above 5 µg/mL had greater reductions in ALT and AST and a greater increase in hemoglobin; these achieved-level findings were not definitive treatment effects and require replication in larger trials designed for liver and hematologic outcomes. (Robinson 2024) (https://pubmed.ncbi.nlm.nih.gov/39069269/) - Diet and lifestyle remain the better-established foundation for metabolic and liver health. Dairy fat is the principal dietary source of C15:0, although circulating odd-chain fatty acids may also be influenced by endogenous production. (Weitkunat 2017) (https://pubmed.ncbi.nlm.nih.gov/28424190/) For people who avoid or tolerate little dairy, C15:0…
Not rated yetMedicine for All People: Food, Nature, Community, and Joy as Part of Whole-Person Care
· 1 hr 6 min
Dr. Geeta Maker-Clark joins the Root Cause Medicine Podcast to discuss ideas from her book, Medicine for All People: Science and Ancient Wisdom for Revolutionary Healing. Drawing from family medicine, integrative medicine, culinary medicine, community health and her own upbringing, she explores a broader view of medicine that includes food, plants, nature, community, service, trust, dance, gratitude, and play. The conversation centers on a simple idea: health is shaped not only by what happens in the clinic, but also by the environments, relationships, resources, cultural traditions, and daily practices that surround a person. Dr. Maker-Clark organizes these ideas into three areas—medicines of the earth, medicines of connection, and medicines of spirit—and discusses how practitioners can think about them alongside conventional medical care. Clinical Takeaways - Food and nutrition are part of whole-person care. Dr. Maker-Clark describes food as a central part of her clinical philosophy and discusses culinary medicine as a way to combine nutrition education with practical cooking skills. Her University of Chicago culinary medicine work includes medical students, community members, and middle school students, with an emphasis on nutrition literacy, accessibility, and culturally relevant food education. (Maker-Clark 2023) (https://pubmed.ncbi.nlm.nih.gov/37836495/) - Nature exposure may support stress regulation and mental well-being. The episode frames time outdoors and connection with the natural environment as accessible ways to support well-being. Research has associated nature exposure with lower perceived and physiologic stress, although study designs, settings, and outcomes vary. (Shuda 2020) (https://pubmed.ncbi.nlm.nih.gov/33066853/) - Social connection deserves attention in clinical assessment. Dr. Maker-Clark emphasizes community, belonging, and service as dimensions of health. Research supports associations between loneliness and social isolation and adverse cardiovascular, brain, mental health, and inflammatory outcomes, although mechanisms and the effectiveness of specific interventions continue to be studied. (Cené 2022) (https://www.ahajournals.org/doi/10.1161/JAHA.122.026493) (Smith 2020) (https://pubmed.ncbi.nlm.nih.gov/32092313/) - Trust includes both healthcare relationships and self-trust. The conversation explores how previous negative healthcare experiences, chronic illness, and unexplained symptoms can affect trust. Dr. Maker-Clark describes rebuilding trust through relationships and small, achievable commitments rather than treating trust as something patients should simply provide. - Dance combines movement, cognition, emotion, and often social interaction. Dance is presented as an accessible form of joyful movement rather than a replacement for clinical care. Research suggests dance can influence cognitive and neuroplasticity-related outcomes, particularly in older adults, although effects vary by population and intervention. (Teixeira-Machado 2019) (https://pubmed.ncbi.nlm.nih.gov/30543905/) (Hewston 2021) (https://academic.oup.com/ageing/article/50/4/1084/6041778) - Gratitude and play can be viewed as practices that support well-being. Gratitude interventions have shown generally modest benefits for well-being and some psychological outcomes. (Diniz 2023) (https://pubmed.ncbi.nlm.nih.gov/37585888/) (Kerry 2023) (https://www.dovepress.com/being-thankful-for-what-you-have-a-systematic-review-of-evidence-for-t-peer-reviewed-fulltext-article-PRBM) Adult play can take many forms, including creativity, competition, collecting, storytelling, exploration, and restorative activities. (Blanche 2024) (https://research.aota.org/ajot/article-abstract/78/4/7804185040/25216/Experiences-of-Adult-Play) Guest: Geeta Maker-Clark, MD Dr. Geeta Maker-Clark is a family and integrative medicine physician whose work spans patient care, nutrition education, culinary medicine, and community health. In the episode,…
Not rated yetBeyond the Label: What Matters in Curcumin and Boswellia Quality
· 24 min
Dr. Holly Lucille, ND, is joined by Ellie Abraham, PhD, to explain why two curcumin or Boswellia supplements may not be equivalent, even when the front of the label looks similar. The conversation covers boswellic acid standardization, AKBA, curcumin delivery systems, piperine, botanical sourcing, finished-product testing, certificates of analysis, and supply-chain controls. Research supports meaningful variation in Boswellia composition and curcumin formulations, making the specific extract and formulation relevant when interpreting product labels and published evidence.https://pubmed.ncbi.nlm.nih.gov/27054914/(Meins 2016) (https://pubmed.ncbi.nlm.nih.gov/27054914/)https://pubmed.ncbi.nlm.nih.gov/36015087/(Mimica 2022) (https://pubmed.ncbi.nlm.nih.gov/36015087/) Clinical Takeaways - “Boswellic acids” describes a group of compounds. Boswellia preparations can contain different proportions of individual boswellic acids, including AKBA, KBA, and alpha- and beta-boswellic acids. Products with similar total boswellic acid claims therefore may not have identical chemical profiles.https://pubmed.ncbi.nlm.nih.gov/27782055/(Mannino 2016) (https://pubmed.ncbi.nlm.nih.gov/27782055/)https://pubmed.ncbi.nlm.nih.gov/27054914/(Meins 2016) (https://pubmed.ncbi.nlm.nih.gov/27054914/) - Curcumin formulation matters. Conventional oral curcumin has low bioavailability, and formulations including phytosomes, liposomes, micelles, and piperine combinations have been studied as strategies to alter absorption. However, different formulations should not automatically be treated as interchangeable because comparative pharmacokinetic results vary.https://pubmed.ncbi.nlm.nih.gov/37008131/(Hegde 2023) (https://pubmed.ncbi.nlm.nih.gov/37008131/)https://pubmed.ncbi.nlm.nih.gov/33877323/(Fança-Berthon 2021) (https://pubmed.ncbi.nlm.nih.gov/33877323/) - Standardization provides more information than an ingredient name alone. Botanical composition can vary with species, growing conditions, extraction, processing, and other supply-chain factors. Standardization and appropriate quality controls can help establish more consistent composition.https://pubmed.ncbi.nlm.nih.gov/18258640/(Ribnicky 2008) (https://pubmed.ncbi.nlm.nih.gov/18258640/)https://pubmed.ncbi.nlm.nih.gov/32955961/(Sarma 2021) (https://pubmed.ncbi.nlm.nih.gov/32955961/) - Potency is only one part of quality. Botanical quality also involves identity, purity, contaminants, adulteration, and finished-product verification. Published investigations have identified labeling and authenticity concerns in both Boswellia and turmeric/curcumin products.https://pubmed.ncbi.nlm.nih.gov/27054914/(Meins 2016) (https://pubmed.ncbi.nlm.nih.gov/27054914/)https://pubmed.ncbi.nlm.nih.gov/34507212/(You 2022) (https://pubmed.ncbi.nlm.nih.gov/34507212/) - Quality does not equal clinical fit. A well-characterized supplement still needs to be considered in the context of the individual patient, including the formulation, dose, supporting evidence, medication use, and potential botanical-drug interactions.https://pubmed.ncbi.nlm.nih.gov/18258642/(van Breemen 2008) (https://pubmed.ncbi.nlm.nih.gov/18258642/) Guest: Ellie Abraham, PhD Ellie Abraham has a PhD in plant biology, with research focused on developing analytical methods for testing finished botanical products. Her background includes botanical chemistry, finished-product testing, standardization, and dietary supplement quality. In this episode, she explains how practitioners can look beyond an ingredient name to assess what a curcumin or Boswellia product is actually formulated to deliver. These five questions best match the broad topics addressed in the episode, particularly searches around Boswellia standardization, AKBA, curcumin absorption, piperine, and supplement quality. Exact search volume is not publicly available from a standard web search. These topics are also represented in published research on botanical quality and curcumin formulation.…
Not rated yetImmunometabolism: What Your Immune System Can Teach You About Metabolic Health
· 59 min
What if metabolism and immune function aren’t separate systems, but part of one continuous conversation? In this episode of the Root Cause Medicine Podcast, Dr. Jeffrey Bland joins Kate Kresge to explore immunometabolism, the study of how immune activity and cellular metabolism influence one another. They discuss how inflammation can affect energy use across tissues, why metabolic health is about far more than weight, and how systems biology is changing the way clinicians think about chronic disease. (O'Neill 2016) (https://pubmed.ncbi.nlm.nih.gov/27396447/) Dr. Bland also introduces emerging inflammatory indices—including the Systemic Immune-Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI)—that can be derived from components of a routine CBC with differential. (Islam 2024) (https://pubmed.ncbi.nlm.nih.gov/38343523/) The conversation explores their potential role as contextual markers of inflammatory activity, while emphasizing how Journeys (https://fullscript.com/lp/dr-bland-signature-series) can help to automate CBC calculations and help create customized reports for practitioners using blood labs values, history, symptoms and more. The episode closes with a practical look at nutrition, polyphenol-rich foods, lifestyle medicine, large-scale health data, and the growing potential for personalized care. Clinical Takeaways from This Episode - Immunometabolism connects immune signaling with cellular energy use. Immune cells alter their metabolic activity when activated, and immune-derived signals can influence the function of tissues throughout the body. (O'Neill 2016) (https://pubmed.ncbi.nlm.nih.gov/27396447/) - Chronic inflammation is a systems-level process. Rather than viewing inflammation as an isolated problem within one organ, immunometabolism highlights communication among adipose tissue, the liver, brain, muscles, immune cells, and other tissues. (Burak 2024) (https://www.sciencedirect.com/science/article/abs/pii/S0002916524004556) (Juárez-Rojas 2024) (https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762024000200001) - A CBC may contain more information than clinicians traditionally use. SII and SIRI combine routinely measured blood-cell populations into indices being studied as markers of systemic inflammatory and immune activity. (Islam 2024) (https://pubmed.ncbi.nlm.nih.gov/38343523/) They should be interpreted in clinical context rather than used independently to diagnose disease or dictate treatment. (Mangoni 2024) (https://link.springer.com/article/10.1007/s10238-024-01294-3) - Lifestyle interventions affect multiple biological systems at once. Dr. Bland discusses dietary patterns rich in diverse plant compounds alongside movement, sleep, and stress management as components of a broader approach to metabolic and immune health. (Koelman 2022) (https://pmc.ncbi.nlm.nih.gov/articles/PMC8803482/) - Practitioners can order Dr. Jeff Bland’s Immunometabolic Journey (https://fullscript.com/lp/dr-bland-signature-series) on Fullscript.com Guest Introduction Dr. Jeffrey Bland is a longtime leader in functional and systems-based approaches to health and one of the influential voices behind the development of functional medicine. His work focuses on translating complex biology—including immunology, metabolism, nutrition, genetics, and systems medicine—into clinically meaningful ways of thinking about health. In this conversation, he brings that systems perspective to immunometabolism (https://fullscript.com/lp/dr-bland-signature-series)and explores how clinicians may begin connecting familiar laboratory data with a deeper understanding of immune and metabolic function. FAQ What is immunometabolism? Immunometabolism examines the two-way relationship between immune function and metabolism. Immune cells require energy to perform their functions, and changes in their metabolic state can influence inflammatory signaling and communication with other tissues. (O'Neill…
Not rated yetOne Hidden Immune Trigger Everyone Misses: A Complex Autoimmune Case Study
· 12 min
One Hidden Immune Trigger Everyone Misses: A Complex Autoimmune Case Study What happens when a patient with multiple autoimmune conditions has already addressed the obvious contributors but continues to experience flares? In this case study episode, Dr. Kate Kresge sits down with clinical nutritionist and IFM-certified practitioner Robyn Puglia to walk through a complex case of polyautoimmunity and persistent immune dysregulation. (Anaya 2014) The patient had already worked with multiple practitioners and addressed gut health, food reactivity, mold, and stress. Robyn explains how additional testing shifted her attention away from the gut and toward an unexpected area, the respiratory tract, and how that finding changed the care plan. (Holers 2018) It's a powerful lesson in clinical reasoning for your most complex patients. (Nissen 2014) 3 Key Takeaways - Autoimmune conditions often travel together. (Rojas-Villarraga 2012) Polyautoimmunity describes more than one autoimmune disease in a single patient, and three or more is known as multiple autoimmune syndrome. (Anaya 2014) Robyn's patient had four. - Don't assume the gut is always the driver. (De Luca 2019)(Holers 2018) When the most plausible contributors have been addressed, Robyn steps back and asks whether another system, exposure, or infection deserves evaluation. (Miller 2012) - Interpret testing in context. A respiratory microbial pattern became an important clue in this case, and Robyn emphasizes reading results alongside symptoms, history, and prior testing rather than treating one test as the whole answer. Guest: Robyn Puglia is a clinical nutritionist and IFM-certified functional medicine practitioner who works with patients at what she calls the "zebra" or even "unicorn" stage: people who have often seen multiple experienced practitioners and already addressed nutrition, metabolic health, circadian rhythms, stress, and gut health. Clinical FAQ How does Robyn approach patients who've "tried everything"? She reviews what's already been addressed, avoids repeating the same investigation, and widens the lens to systems, exposures, or infections that haven't yet been evaluated. (Miller 2012) Why look beyond the gut in autoimmunity? The gut is a common and important contributor, but it isn't always the primary one. In this case, testing pointed to the respiratory tract despite the absence of obvious respiratory symptoms. (De Luca 2019) (Holers 2018) Can one case guide care for other patients? An individual case illustrates clinical reasoning. It doesn't establish that the same testing or intervention will produce similar results in other patients, which is why Robyn pairs findings with the full clinical picture. (Nissen 2014) Ready to elevate your practice? This episode is sponsored by Fullscript (https://fullscript.com/?utm_campaign=rootcausemedicinepodcast&utm_medium=podcast&utm_source=fullscript-academy), a comprehensive care delivery platform designed to support whole-person, integrative healthcare. Fullscript helps clinicians bring supplement dispensing, lab ordering, and patient education into one centralized workflow. For more practitioner education on supplements, nutrition, and evidence-informed clinical care, visit Fullscript Academy at academy.fullscript.com. Disclaimer: The views expressed on this podcast are those of the hosts and guests and don’t necessarily reflect those of Fullscript or any affiliated organizations. This podcast is for informational and educational purposes only and is not intended to be medical advice. For your safety, always check with your doctor or healthcare provider before making changes to your health routine. References - Anaya, J.-M. (2014). The diagnosis and clinical significance of polyautoimmunity. Autoimmunity Reviews, 13(4–5), 423–426. https://www.sciencedirect.com/science/article/abs/pii/S1568997214000615 - De Luca, F., & Shoenfeld, Y. (2019). The microbiome in autoimmune diseases. Clinical and…
Not rated yetTG6, Lymphocyte Patterns and Early Autoimmunity
· 1 hr 7 min
What if some of the immune activity we’re looking for isn’t showing up where we expect to find it? In this episode, I sit down with Robyn Puglia of Cyrex Laboratories to explore TG6, lymphocyte patterns, and early autoimmunity—and specialized testing many practitioners may not realize is available through Cyrex Wheat Burden panel, the Lymphocyte Map, and Array 5. We look at neurological manifestations of gluten-related disease, what different immune cell populations may add to the clinical picture, and how autoantibodies can sometimes appear before autoimmune disease is diagnosed. The bigger question: Can seeing more of the immune story help us ask better questions about what may be driving a complex presentation? What You’ll Learn - Why gluten reactivity isn’t always a gut story. TG6 has been studied in gluten-related neurological disorders, particularly gluten ataxia. (Hadjivassiliou 2019) (https://www.cghjournal.org/article/S1542-3565(19)30278-2/fulltext) We discuss why neurological symptoms may belong in the gluten conversation and what Cyrex Wheat Burden Panel is designed to investigate beyond conventional celiac markers. (Mearns 2019) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412791/) - What your lymphocyte count may not tell you. T cells, B cells, natural killer cells, and their subsets have different jobs. Robyn explains how the Cyrex Lymphocyte Map looks at these populations and how patterns may help practitioners decide what to investigate next. - Why autoimmunity may start before the diagnosis. Disease-associated autoantibodies can precede clinical disease in several autoimmune conditions. (Ma 2017) (https://www.sciencedirect.com/science/article/abs/pii/S0896841117303542) We explore Cyrex Array 5, tissue-associated autoantibodies, and what these earlier immune signals may—and may not—tell us. (Frazzei 2022) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281565/) Meet Robyn Puglia Robyn Puglia’s work with celiac disease, neurological symptoms, autoimmunity, and complex chronic illness pushed her to ask what the immune system might be telling us beyond a routine workup. Today, as Vice President of Practitioner Education at Cyrex Laboratories, she teaches practitioners how to think about specialized immune testing without treating an abnormal biomarker as a diagnosis. FAQ What is TG6, and why does it matter? Most practitioners know tissue transglutaminase 2 (TG2) from celiac testing. Tissue transglutaminase 6 (TG6) has been studied in gluten-related neurological disorders, particularly gluten ataxia. (Hadjivassiliou 2019) (https://www.cghjournal.org/article/S1542-3565(19)30278-2/fulltext) TG6 isn’t part of routine guideline-supported celiac screening, but it highlights an important point: gluten-related immune disease can have extraintestinal manifestations, including neurological symptoms. (Mearns 2019) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412791/) (Rubio-Tapia 2023) (https://pubmed.ncbi.nlm.nih.gov/36602836/) What is Cyrex Wheat Burden Panel? The Wheat Burden panel evaluates antibody reactivity to multiple wheat-associated antigens and transglutaminases, including TG6. It provides a broader look at wheat-associated immune reactivity than conventional celiac serology. It shouldn’t replace established evaluation for celiac disease or wheat allergy; the value of additional biomarkers depends on the clinical question and the evidence supporting their intended use. (Rubio-Tapia 2023) (https://pubmed.ncbi.nlm.nih.gov/36602836/) (Leonard 2017) (https://jamanetwork.com/journals/jama/article-abstract/2648637) What can the Lymphocyte Map show? The Cyrex Lymphocyte Map examines populations and subsets of T cells, B cells, and natural killer cells. Instead of asking whether one value is simply high or low, Robyn looks at the pattern and asks what might explain it. Infection? Medication effects? Immune dysfunction? Another clinical process? The pattern isn’t the diagnosis. It helps sharpen…
Not rated yetThe Missing Piece in Youth Sports: Building Healthy, High-Performing Teen Athletes
· 55 min
What does it take to help young athletes perform at their best—not just today, but for decades to come? In this episode of Root Cause Medicine, Dr. Kate Kresge sits down with emergency medicine physician and functional medicine practitioner Dr. Erik Peterson to discuss a whole-person approach to adolescent athletic performance. Drawing from more than 20 years in emergency medicine, his background as a collegiate athlete, and his work caring for young competitors, Dr. Peterson explains why optimizing performance starts with supporting the developing body rather than simply pushing it harder. The conversation explores how nutrition, sleep, recovery, body composition, metabolic health, and resilience influence athletic success during adolescence. Dr. Peterson also shares why he believes healthcare providers, coaches, and parents have an opportunity to improve long-term health by focusing on foundational physiology during these critical developmental years. Beyond sports performance, this episode is also a conversation about the evolution of medicine—from treating illness in the emergency department to helping people stay healthy through proactive, root-cause care. Listen If You... - Treat adolescent athletes in your practice - Coach youth sports - Parent a competitive athlete - Work in sports medicine, functional medicine, pediatrics, or primary care - Want to better understand the foundations of long-term athletic performance What You'll Learn - How Dr. Peterson gets his athletes results using only food, supplements and lifestyle - Common mistakes young athletes make when trying to optimize performance - Why body composition and metabolic health matter more than weight alone - The important role parents and coaches play in creating healthy performance habits - Dr. Peterson's journey from emergency medicine physician to functional medicine practitioner Who Is Dr. Erik Peterson? Dr. Erik Peterson is a board-certified emergency medicine physician who has practiced emergency medicine for more than two decades while also leading a precision medicine practice focused on performance optimization, men's health, women's health, and preventive care. A former collegiate athlete, he combines his experience in acute care with evidence-informed lifestyle medicine to help athletes and active individuals optimize health, resilience, and long-term performance. Learn more about his program at https://firstcallperformance.com/ Key Takeaways - Performance is Built Outside the Gym: Training is only one part of athletic success. Nutrition, sleep, recovery, stress management, and overall metabolic health create the foundation that allows athletes to adapt and perform. (Mountjoy 2023) (https://pubmed.ncbi.nlm.nih.gov/37752011/) (Cunha 2023) (https://pmc.ncbi.nlm.nih.gov/articles/PMC10354314/) - Adolescence Is a Critical Opportunity: The teenage years represent an important period for developing healthy habits that influence performance, injury risk, and long-term health. (Blyth 2025) (https://onlinelibrary.wiley.com/doi/10.1111/obr.13909) - Parents and Coaches Matter: The adults surrounding young athletes often shape their relationship with food, training, recovery, and health. Creating supportive environments can have lasting effects beyond sports. (Baceviciene 2023) (https://www.mdpi.com/2072-6643/15/12/2724) - Functional Medicine Complements Performance Care: Looking upstream at nutrition, biomarkers, lifestyle, and physiology may help identify opportunities to support athletic performance while promoting long-term wellness. (Haller 2023) (https://pubmed.ncbi.nlm.nih.gov/37204619/) Want to elevate your practice? This episode is sponsored by Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates), a comprehensive care delivery platform designed to support whole-person, integrative healthcare. Fullscript…
Not rated yetHow to Build a Thriving Practice Without Burning Out
· 47 min
One of my favorite parts of hosting the Root Cause Medicine Podcast is introducing you to practitioners who are making a real difference—not only in the lives of their patients, but in the lives of other clinicians. Today's guest is Lesli Bitel, a registered dietitian whose career has taken a path that many practitioners may recognize pieces of. She began in clinical practice, spent years in leadership roles across the pharmaceutical and diagnostics industries, and eventually found her way back to patient care with an entirely new perspective. Today, she helps practitioners build businesses that allow them to do their best work without burning themselves out along the way. Because the reality is, most of us were trained to care for patients. Very few of us were taught how to build a practice that can sustainably support both our patients and ourselves. In this conversation, Lesli shares how her experience in business transformed the way she thought about practice ownership. We talk about why marketing doesn't have to feel uncomfortable, how thoughtful systems can create more time for patient care, and why building a successful practice isn't about doing more—it's about building one that's aligned with your values. Whether you're just starting your practice or looking for a more sustainable way to grow, I think you'll come away from this conversation with practical ideas—and maybe a little reassurance—that it's possible to build a thriving practice without losing sight of why you became a clinician in the first place. In This Conversation - Lesli's journey from aspiring clinician to healthcare executive and back to patient care - What years in corporate healthcare taught her about running a successful practice - Why so many practitioners feel confident clinically but overwhelmed by the business side of medicine - How marketing can become an authentic extension of patient education - Simple systems that create more time, less stress, and better patient experiences - The connection between practice design, boundaries, and practitioner well-being - Building a practice that reflects your strengths, values, and vision for your career A Few Takeaways I'll Be Thinking About - Authentic marketing starts with clarity, not self-promotion. - Good systems free you to spend more time doing what only you can do. - Sustainable growth should support your life, not just your business. Who Should Listen? This episode is for any clinician who has ever wondered: - How do I build a practice that actually feels sustainable? - How can I grow without sacrificing patient care? - Is there a way to market my practice that still feels authentic? - What does long-term success really look like? Whether you're starting your first practice or reimagining an established one, I think you'll find something valuable in Lesli's story. Episode Timeline 00:00 — Welcome and introduction 02:30 — Lesli's journey into healthcare 05:00 — Lessons from corporate healthcare 10:00 — Why clinicians struggle with practice ownership 18:00 — Rethinking marketing 28:00 — Systems that support sustainable growth 39:00 — Burnout, boundaries, and practice design 48:00 — Building a practice around your values 55:00 — Final reflections Want to elevate your practice? This episode is sponsored by Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates), a comprehensive care delivery platform designed to support whole-person, integrative healthcare. Fullscript (https://fullscript.com/?utm_source=fame&utm_medium=podcast&utm_campaign=fs_provider_2026-01_fame_2026-sibo-updates)allows clinicians to streamline supplement dispensing, lab ordering, and patient education in one free, centralized system—helping reduce administrative burden while supporting clinical decision-making. For practitioners, Fullscript…
Not rated yetRoot, Leaf, Extract: What Matters in Ashwagandha
· 18 min
Dr. Holly Lucille is joined by Ellie Abraham, PhD, to explain why two ashwagandha supplements may not be the same, even when they list the same ingredient. (Thalhamer 2024) (https://www.explorationpub.com/Journals/eff/Article/101046) This conversation covers differences between root and leaf extracts, withanolide standardization, botanical identity testing, certificates of analysis, and manufacturing quality. It also emphasizes that a well-made product may still not be appropriate for every patient. (NCCIH 2025) (https://www.nccih.nih.gov/health/ashwagandha) Clinical Takeaways - Plant part matters. Ashwagandha root, leaf, and combined extracts may have different chemical profiles and should not automatically be treated as interchangeable. (Chaurasiya 2008) (https://pubmed.ncbi.nlm.nih.gov/17879227/) - Higher is not always better. The most concentrated product is not necessarily the safest or most effective. Clinical relevance depends on the extract, dose, intended use, and supporting research. (Thalhamer 2024) (https://www.explorationpub.com/Journals/eff/Article/101046) (NCCIH 2025) (https://www.nccih.nih.gov/health/ashwagandha) - Quality testing matters. Botanical authentication, contaminant testing, certificates of analysis, and cGMP compliance can help confirm that a product meets its specifications. (ECFR 2026) (https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111) - Quality does not equal clinical fit. Patient history, medications, allergies, diagnoses, and potential interactions must still be considered. (NCCIH 2025) (https://www.nccih.nih.gov/health/ashwagandha) Guest: Ellie Abraham has a PhD in plant biology and a background in analytical chemistry, ethnobotany, botanical testing, and dietary supplement quality control. She explains how manufacturers and laboratories verify botanical identity, plant part, standardization, contaminants, and product documentation. Clinician FAQ 1. Are all ashwagandha supplements the same? No. Products may differ in plant part, extraction method, dose, standardization, chemical profile, and manufacturing quality. (Thalhamer 2024) (https://www.explorationpub.com/Journals/eff/Article/101046) 2. Why does ashwagandha root versus leaf matter? The root and leaf of ashwagandha contain different combinations of plant compounds. These differences may affect the product’s clinical properties, supporting research, and safety profile. (Chaurasiya 2008) (https://pubmed.ncbi.nlm.nih.gov/17879227/) 3. What does “standardized to 5% withanolides” mean? It means withanolides account for approximately 5% of the tested material. It does not identify each individual withanolide or describe the rest of the extract. (Thalhamer 2024) (https://www.explorationpub.com/Journals/eff/Article/101046) 4. Is a higher withanolide percentage better? Not necessarily. A higher percentage does not automatically mean that a product is safer or more effective. The appropriate concentration depends on the extract, dose, intended use, and supporting research. (Thalhamer 2024) (https://www.explorationpub.com/Journals/eff/Article/101046) 5. Can ashwagandha cause liver injury? Rare cases of liver injury associated with ashwagandha products have been reported. The exact cause and individual risk factors remain uncertain, but practitioners should consider supplement use when evaluating unexplained liver symptoms or abnormal liver tests. (NCBI 2012) (https://www.ncbi.nlm.nih.gov/books/NBK548536/?utm_source=chatgpt.com) (Philips 2023) (https://pubmed.ncbi.nlm.nih.gov/37756041/) (Björnsson 2020) (https://pubmed.ncbi.nlm.nih.gov/31991029/) Timestamps / Key Moments 00:01:43 Ellie Abraham’s background in botanical testing 00:02:36 The ashwagandha leaf discussion in India 00:04:00 Differences between root and leaf 00:05:44 How botanical identity is verified 00:07:25 Why standardization matters 00:09:07 Why higher withanolides are not always better 00:10:56 Comparing two ashwagandha products 00:12:17 Red…
Not rated yetFood, Mold, Ticks, and the Immune System with Alletess Medical Laboratory
· 35 min
Summary This episode explores the role of immune-mediated testing in the evaluation of complex, chronic symptoms that may not respond to conventional approaches. Dr. Jessica Christie is joined by Veronica Kent, CEO of Alletess Medical Laboratory, and Kristen Trainer, Registered Dietitian and Clinical Educator, to discuss food allergies, food sensitivities, mold exposure, Candida, Alpha-gal syndrome, elimination diets, and the evolving landscape of laboratory testing. The conversation examines the differences between IgE-mediated food allergies and IgG food sensitivity testing, when clinicians may consider specialized laboratory assessments, and the importance of combining laboratory data with a comprehensive patient history and individualized care plans. The guests also discuss laboratory quality standards, patient education, and why test interpretation should be viewed as one component of clinical decision-making rather than a standalone diagnostic tool. (Santos 2023) (https://onlinelibrary.wiley.com/doi/10.1111/all.15902) Clinical Takeaways from This Episode - Not all adverse food reactions are food allergies. The episode distinguishes between IgE-mediated food allergies and other forms of food-related symptoms, including food sensitivities, while acknowledging that diagnostic approaches differ depending on the clinical presentation. (Sicherer 2018) (https://www.sciencedirect.com/science/article/abs/pii/S0091674917317943) - Patient history remains foundational. Laboratory testing should be interpreted alongside symptoms, clinical history, dietary patterns, and physical examination rather than in isolation. (Santos 2023) (https://onlinelibrary.wiley.com/doi/10.1111/all.15902) - Elimination diets require structured implementation. The guests discuss elimination and systematic food reintroduction as part of evaluating whether certain foods may contribute to symptoms, emphasizing individualized guidance and monitoring. (Santos 2023) (https://onlinelibrary.wiley.com/doi/10.1111/all.15902) - Alpha-gal syndrome is an emerging clinical consideration. Tick-associated mammalian meat allergy is becoming increasingly recognized and may present with delayed allergic reactions that can be difficult to identify. (Platts-Mills 2025) (https://onlinelibrary.wiley.com/doi/10.1111/imr.70035) (Thompson 2023) (https://www.cdc.gov/mmwr/volumes/72/wr/mm7230a2.htm) - Environmental exposures may contribute to symptom burden. Mold exposure is discussed as one possible consideration in select patients presenting with persistent respiratory or inflammatory symptoms, although appropriate testing strategies remain an area of ongoing research and debate. (Cai 2024) (https://www.sciencedirect.com/science/article/abs/pii/S0360132324000684) - Patient education is essential. Laboratory testing alone does not improve outcomes; patients benefit from clear interpretation, education, and individualized follow-up plans. (Santos 2025) (https://onlinelibrary.wiley.com/doi/10.1111/all.16345) - Quality systems matter in laboratory medicine. The discussion highlights the importance of standardized laboratory procedures, quality assurance, and timely reporting in supporting clinical decision-making. (Pillai 2025) (https://pmc.ncbi.nlm.nih.gov/articles/PMC12133829/) - Guest Introduction Veronica Kent Veronica Kent is the Chief Executive Officer and owner of Alletess Medical Laboratory. She has spent decades working in specialty laboratory medicine and oversees operations focused on allergy, immunology, and immune-based laboratory testing. During the episode, she discusses laboratory quality systems, emerging testing technologies, and the role of clinician education in laboratory medicine. Website:https://foodallergy.comhttps://foodallergy.com Kristen Trainer, RD Kristen Trainer is a Registered Dietitian and Clinical Educator at Alletess Medical Laboratory. She has worked with clinicians and patients for more than two decades, helping interpret laboratory…
Not rated yetPerimenopause as a Portal to Power with Dr. Aviva Romm
· 1 hr 24 min
What if the most powerful shift in how we practice medicine starts with one person deciding to do it differently? Aviva’s story is that kind of shift. Long before she ever sat in a medical classroom, she had already built a life as a midwife, herbalist, and mother of four who was deeply embedded in her community. Then, in what most of us would consider the busiest, most demanding years of life - years that often overlap with perimenopause - she made a radical decision: she went back to school. Back into training. Back into the system she wanted to help change. Not because something was broken, but because she saw what was missing. That’s what makes this episode different. It’s about what happens when women get to reframe the perimenopausal transition as one of the most powerful, generative, expansive years of their lives. Instead of accepting the status quo, Dr. Aviva Romm built an entirely different way of seeing things - one that doesn’t reduce symptoms to problems, but places them in context. One that connects sleep, stress, nourishment, physiology, and even relationships into a bigger picture of health. You can feel that perspective ripple through the entire conversation. It gently challenges the idea that you need more interventions, more testing, more fixing, and replaces it with something both simpler and harder: paying attention, understanding what your body is asking for, and supporting it instead of overriding it. By the end, something shifts. You’re not just thinking differently about perimenopause - you’re thinking differently about what’s possible during this phase of life. And maybe, like Aviva did, you start to wonder: what could change if perimenopause wasn’t seen as the end of something, but the beginning of something else entirely? Clinical Takeaways from This Episode - A root-cause, whole-person approach to perimenopause may support more sustainable outcomes. Perimenopause often includes symptoms like sleep disruption, mood changes, and cycle irregularities, and may benefit from a broader, individualized care approach rather than a single intervention (Santoro et al., 2018). - Stress physiology and HPA axis patterns may influence how symptoms show up. Chronic stress is associated with changes in inflammatory signaling and neuroendocrine regulation, which may shape mood, immune function, and metabolic health (Russell, 2019). - Sleep is foundational—and CBT-I is an evidence-informed place to start. Cognitive Behavioral Therapy for Insomnia (CBT-I) is supported by clinical evidence and may help improve sleep quality without medication in many individuals (Rossman, 2019). - Connection and community are not “extras”—they’re part of physiology. Social isolation has been associated with increased mortality risk, which reinforces the importance of connection as part of whole-person care (Naito et al., 2023). - Thoughtful, targeted lab testing supports better clinical decision-making. Strategic use of labs—guided by symptoms and clinical context—may reduce unnecessary testing and help clinicians focus on meaningful data. Guest Introduction Dr. Aviva Romm (https://avivaromm.com/), MD, is a Yale-trained physician, herbalist, and midwife with over four decades of experience in women’s health. She has trained hundreds of clinicians in integrative and functional medicine and is the author of multiple bestselling books, including Hormone Intelligence and The Adrenal Thyroid Revolution. Her work bridges conventional and integrative medicine in a way that centers women and their paths to thriving. Interested in advancing your clinical training? Explore Dr. Aviva Romm’s Women’s Integrative Functional Medicine Certification Program (https://avivaromm.com/courses/womens-integrative-and-functional-medicine/). Use code FULLSCRIPT26 in the “How did you learn about the course?” box to receive $1,000 off. FAQ: Clinician & Patient Questions on Perimenopause and Integrative Care What symptoms are common during…
Not rated yetIntegrative and Functional Nutrition Dietitians: How They Amplify Care
· 38 min
What happens when patients leave an integrative or functional medicine appointment with multiple recommendations but limited practical support for implementation? In this episode, Kate Kresge sits down with Monique Richard, Holly Van Poots, and Sudha Raj to discuss the evolving role of Registered Dietitian Nutritionists (RDNs) trained in Integrative and Functional Nutrition (IFN). The conversation centers on the Revised 2025 Scope and Standards of Practice for RDNs in Nutrition in Integrative and Functional Medicine, which clarifies the scope, standards, and clinical contribution of IFN practitioners. (Crowe-White 2025) (https://www.cdrnet.org/vault/2459/web//20251215%20NIFM%20Article%20FINAL%20-%202.pdf) Together they explore why nutrition may remain underused in some conventional care settings, including concerns that many medical providers receive limited formal nutrition training. (Adams 2010) (https://pubmed.ncbi.nlm.nih.gov/20736683/) They also discuss why sustained behavior change often requires more time, context, and follow-up than a brief visit can provide, and why food choices are shaped by more than nutrient content alone. The discussion highlights how IFN dietitians can help translate complex plans into sustainable daily habits while helping patients connect symptoms, lifestyle patterns, culture, stress, and nutrition. The episode makes a practical case for team-based care and shows how integrative nutrition practitioners can help bridge the gap between clinical recommendations and meaningful long-term change. Clinical Takeaways From This Episode Behavior Change Is Often the Missing Piece Many visits focus on diagnosis and treatment decisions, while meaningful behavior change takes time, relationship-building, and ongoing support. (Crowe-White 2025) (https://www.cdrnet.org/vault/2459/web//20251215%20NIFM%20Article%20FINAL%20-%202.pdf) (Körner 2016) (https://pubmed.ncbi.nlm.nih.gov/26709985/) IFN dietitians help patients put recommendations into practice in real-world settings. Food Is More Than Nutrients Food choices are shaped by culture, identity, family history, emotional experience, access, and lifestyle. Accounting for these factors may help make nutrition recommendations more realistic, acceptable, and sustainable; effects on clinical outcomes depend on the condition, intervention, and patient context. (Odoms-Young 2024) (https://www.ncbi.nlm.nih.gov/books/NBK611347/) (Crowe-White 2025) (https://www.cdrnet.org/vault/2459/web//20251215%20NIFM%20Article%20FINAL%20-%202.pdf) Nutrition Is Central to Complex Chronic Disease Many patients present with concerns where nutrition may be one component of care, including issues related to digestive health, metabolic health, immune function, and quality of life. (Crowe-White 2025) (https://www.cdrnet.org/vault/2459/web//20251215%20NIFM%20Article%20FINAL%20-%202.pdf) (Moloney 2025) (https://pubmed.ncbi.nlm.nih.gov/41083126/) Dietitians Serve as Translators of Functional Medicine Plans Many patients leave appointments with extensive recommendations. IFN practitioners can help patients prioritize, personalize, and implement clinician recommendations within the patient’s preferences, resources, culture, and care plan. (Moloney 2025) (https://pubmed.ncbi.nlm.nih.gov/41083126/) (Senkus 2024) (https://www.sciencedirect.com/science/article/pii/S0002916524004039) Team-Based Care Improves Patient Support Integrative care tends to work best when physicians, naturopathic doctors, nurse practitioners, health coaches, and nutrition professionals collaborate on whole-person care. (Körner 2016) (https://pubmed.ncbi.nlm.nih.gov/26709985/) (Crowe-White 2025) (https://www.cdrnet.org/vault/2459/web//20251215%20NIFM%20Article%20FINAL%20-%202.pdf) Guest Introduction Monique Richard, MS, RDN, LDN Monique Richard is an experienced registered dietitian nutritionist specializing in integrative and functional nutrition. Known for her practical and patient-centered approach, she…
Not rated yet